Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Use of performance-enhancing substances.

Jorge Gomez,

    Pediatrics
    |April 5, 2005
    PubMed
    Summary

    Performance-enhancing substances, including supplements and drugs, lack safety data in youth. The American Academy of Pediatrics condemns their use and supports elimination efforts in children and adolescents.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ten-year subtype survival and systemic-therapy pathways analysis after breast-cancer recurrence in the LACRN MPBC multicountry cohort study.

    Lancet regional health. Americas·2026
    Same author

    The Molecular Biology and Replication Cycle of Infectious Pancreatic Necrosis Virus.

    Viruses·2026
    Same author

    Phase 1/1b study of direct intratumoral injection of pleural mesothelioma of immunostimulant prior to surgical resection.

    The Journal of thoracic and cardiovascular surgery·2026
    Same author

    Tailoring Ankle-Foot Orthoses Stiffness to End-Users' Needs: Which Performance Variables Matter?

    IEEE ... International Conference on Rehabilitation Robotics : [proceedings]·2025
    Same author

    Long term side effects after volumetric modulated arc therapy to the pleura in patients with malignant pleural mesothelioma.

    Lung cancer (Amsterdam, Netherlands)·2025
    Same author

    Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women.

    Cancer research communications·2025

    Area of Science:

    • Pediatric Health
    • Sports Medicine
    • Substance Use

    Background:

    • Performance-enhancing substances (PES) encompass supplements, medications, and illicit drugs.
    • Limited data exist on the safety and efficacy of commonly used PES in pediatric populations.
    • Adolescent use of PES is a growing concern within sports and general health contexts.

    Purpose of the Study:

    • To define performance-enhancing substances for a general audience.
    • To highlight the critical lack of safety and efficacy data for PES in children and adolescents.
    • To establish a stance on PES use in pediatric populations.

    Main Methods:

    • Literature review to identify widely used performance-enhancing substances.
    • Analysis of existing data regarding efficacy and safety in pediatric populations.
    • Development of a policy statement based on current evidence and ethical considerations.

    Main Results:

    • A functional definition of performance-enhancing substances was established.
    • A significant deficit in research concerning the safety and efficacy of PES in children and adolescents was identified.
    • No data were found to support the use of these substances in pediatric populations.

    Conclusions:

    • The American Academy of Pediatrics strongly condemns the use of performance-enhancing substances by children and adolescents.
    • Efforts to eliminate PES use among young individuals are vigorously endorsed.
    • Further research is warranted, but the current lack of evidence supports a precautionary approach.

    Related Experiment Videos